These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33203610)

  • 1. The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment.
    Gaebel W; Stricker J; Hasan A; Falkai P; McIntyre JS; Kerst A
    Schizophr Res; 2021 Mar; 229():137-139. PubMed ID: 33203610
    [No Abstract]   [Full Text] [Related]  

  • 2. The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples.
    Gaebel W; Stricker J; Riesbeck M
    Schizophr Res; 2020 Nov; 225():4-14. PubMed ID: 31806527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating schizophrenia: the quality of evidence behind treatment recommendations and how it can improve.
    Aran G; Hicks C; Demand A; Johnson AL; Beaman J; Bailey Y; Haught M; Lane A; Sinnett P; Vassar M
    BMJ Evid Based Med; 2020 Aug; 25(4):138-142. PubMed ID: 31672699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term medication in schizophrenic psychoses].
    Gaebel W
    Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S26-31. PubMed ID: 10907610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of schizophrenia].
    Houy-Durand E; Thibaut F
    Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy in schizophrenia.
    Marder SR
    Curr Psychiatr Ther; 1983; 22():141-50. PubMed ID: 6145546
    [No Abstract]   [Full Text] [Related]  

  • 7. [Revised S3 guidelines on schizophrenia : Developmental process and selected recommendations].
    Hasan A; Falkai P; Lehmann I; Janssen B; Wobrock T; Zielasek J; Gaebel W
    Nervenarzt; 2020 Jan; 91(1):26-33. PubMed ID: 31605161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia].
    Delessert D; Pomini V; Grasset F; Baumann P
    Encephale; 2008 Jan; 34(1):93-100. PubMed ID: 18514156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine in the long-term treatment of schizophrenia.
    Kane J
    Br J Psychiatry Suppl; 1999; (37):26-9. PubMed ID: 10211138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lifelong relapse prevention with antipsychotics in schizophrenia].
    Hasan A; Wobrock T
    Psychiatr Prax; 2010 Sep; 37(6):268-70. PubMed ID: 20803409
    [No Abstract]   [Full Text] [Related]  

  • 13. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.
    Hasan A; Falkai P; Wobrock T; Lieberman J; Glenthoj B; Gattaz WF; Thibaut F; Möller HJ;
    World J Biol Psychiatry; 2013 Feb; 14(1):2-44. PubMed ID: 23216388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the metabolic and economic consequences of long-term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost-effectiveness analysis.
    McIntyre RS; Cragin L; Sorensen S; Naci H; Baker T; Roussy JP
    J Eval Clin Pract; 2010 Aug; 16(4):744-55. PubMed ID: 20545800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longterm maintenance therapy with depot haloperidol in schizophrenia.
    Zbytovský J
    Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alteration of the guidelines on pharmaceuticals of the National Committee of Physicians and Health Insurers with regard to atypical neuroleptics. Statement of the German Scoiety of Psychiatry, Psychotherapy and Neurology (DGPPN)].
    Fritze J; Schmauss M;
    Nervenarzt; 2003 Jan; 74(1):97-9. PubMed ID: 12685448
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
    Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
    Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional antipsychotic medications for schizophrenia.
    Dixon LB; Lehman AF; Levine J
    Schizophr Bull; 1995; 21(4):567-77. PubMed ID: 8749885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
    Benoit M; Pon J; Zimmermann MA
    Encephale; 2009 Jan; Suppl 3():S87-90. PubMed ID: 19268184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.